Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: New Zealand Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20071
20091
20122
20142
20161
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Sanofi2
ARCAGY/ GINECO GROUP1
Achieve Life Sciences1
Amgen1
AstraZeneca1
Australasian Gastro-Intestinal Trials Group1
Checkpoint Therapeutics, Inc.1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis13
Carcinoma, Non-Small-Cell Lung4
Adenocarcinoma2
Breast Neoplasms2
Colorectal Neoplasms2
Lung Neoplasms2
Blood Protein Disorders1
Bone Diseases1
Bone Marrow Diseases1
Bone Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.